These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11500501)

  • 21. The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer.
    Saloman DS; Bianco C; Ebert AD; Khan NI; De Santis M; Normanno N; Wechselberger C; Seno M; Williams K; Sanicola M; Foley S; Gullick WJ; Persico G
    Endocr Relat Cancer; 2000 Dec; 7(4):199-226. PubMed ID: 11174844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The EGF-CFC protein one-eyed pinhead is essential for nodal signaling.
    Gritsman K; Zhang J; Cheng S; Heckscher E; Talbot WS; Schier AF
    Cell; 1999 Apr; 97(1):121-32. PubMed ID: 10199408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads.
    Kumar A; Novoselov V; Celeste AJ; Wolfman NM; ten Dijke P; Kuehn MR
    J Biol Chem; 2001 Jan; 276(1):656-61. PubMed ID: 11024047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. O-linked fucose is present in the first epidermal growth factor domain of factor XII but not protein C.
    Harris RJ; Ling VT; Spellman MW
    J Biol Chem; 1992 Mar; 267(8):5102-7. PubMed ID: 1544894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the glycosylphosphatidylinositol-anchor signal sequence of human Cryptic with a hydrophilic extension.
    Watanabe K; Nagaoka T; Strizzi L; Mancino M; Gonzales M; Bianco C; Salomon DS
    Biochim Biophys Acta; 2008 Dec; 1778(12):2671-81. PubMed ID: 18930707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of a recombinant human cripto-1 protein.
    Seno M; DeSantis M; Kannan S; Bianco C; Tada H; Kim N; Kosaka M; Gullick WJ; Yamada H; Salomon DS
    Growth Factors; 1998; 15(3):215-29. PubMed ID: 9570042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-function analysis of the EGF-CFC family member Cripto identifies residues essential for nodal signalling.
    Minchiotti G; Manco G; Parisi S; Lago CT; Rosa F; Persico MG
    Development; 2001 Nov; 128(22):4501-10. PubMed ID: 11714675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cripto forms a complex with activin and type II activin receptors and can block activin signaling.
    Gray PC; Harrison CA; Vale W
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5193-8. PubMed ID: 12682303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammalian Notch1 is modified with two unusual forms of O-linked glycosylation found on epidermal growth factor-like modules.
    Moloney DJ; Shair LH; Lu FM; Xia J; Locke R; Matta KL; Haltiwanger RS
    J Biol Chem; 2000 Mar; 275(13):9604-11. PubMed ID: 10734111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Requirement of glycosylphosphatidylinositol anchor of Cripto-1 for trans activity as a Nodal co-receptor.
    Watanabe K; Hamada S; Bianco C; Mancino M; Nagaoka T; Gonzales M; Bailly V; Strizzi L; Salomon DS
    J Biol Chem; 2007 Dec; 282(49):35772-86. PubMed ID: 17925387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion.
    Sakuma R; Ohnishi Yi Y; Meno C; Fujii H; Juan H; Takeuchi J; Ogura T; Li E; Miyazono K; Hamada H
    Genes Cells; 2002 Apr; 7(4):401-12. PubMed ID: 11952836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cripto localizes Nodal at the limiting membrane of early endosomes.
    Blanchet MH; Le Good JA; Oorschot V; Baflast S; Minchiotti G; Klumperman J; Constam DB
    Sci Signal; 2008 Nov; 1(45):ra13. PubMed ID: 19001664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering of a mammalian O-glycosylation pathway in the yeast Saccharomyces cerevisiae: production of O-fucosylated epidermal growth factor domains.
    Chigira Y; Oka T; Okajima T; Jigami Y
    Glycobiology; 2008 Apr; 18(4):303-14. PubMed ID: 18252777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical synthesis, structural modeling, and biological activity of the epidermal growth factor-like domain of human cripto.
    Lohmeyer M; Harrison PM; Kannan S; DeSantis M; O'Reilly NJ; Sternberg MJ; Salomon DS; Gullick WJ
    Biochemistry; 1997 Apr; 36(13):3837-45. PubMed ID: 9092813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1.
    Watanabe K; Nagaoka T; Lee JM; Bianco C; Gonzales M; Castro NP; Rangel MC; Sakamoto K; Sun Y; Callahan R; Salomon DS
    J Cell Biol; 2009 Nov; 187(3):343-53. PubMed ID: 19948478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two distinct pathways for O-fucosylation of epidermal growth factor-like or thrombospondin type 1 repeats.
    Luo Y; Nita-Lazar A; Haltiwanger RS
    J Biol Chem; 2006 Apr; 281(14):9385-92. PubMed ID: 16464858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lunatic fringe, manic fringe, and radical fringe recognize similar specificity determinants in O-fucosylated epidermal growth factor-like repeats.
    Rampal R; Li AS; Moloney DJ; Georgiou SA; Luther KB; Nita-Lazar A; Haltiwanger RS
    J Biol Chem; 2005 Dec; 280(51):42454-63. PubMed ID: 16221665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A GPI processing phospholipase A2, PGAP6, modulates Nodal signaling in embryos by shedding CRIPTO.
    Lee GH; Fujita M; Takaoka K; Murakami Y; Fujihara Y; Kanzawa N; Murakami KI; Kajikawa E; Takada Y; Saito K; Ikawa M; Hamada H; Maeda Y; Kinoshita T
    J Cell Biol; 2016 Dec; 215(5):705-718. PubMed ID: 27881714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The type 1 (EGFR-related) family of growth factor receptors and their ligands.
    Prigent SA; Lemoine NR
    Prog Growth Factor Res; 1992; 4(1):1-24. PubMed ID: 1355372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural insights into the interaction between the Cripto CFC domain and the ALK4 receptor.
    Calvanese L; Saporito A; Oliva R; D' Auria G; Pedone C; Paolillo L; Ruvo M; Marasco D; Falcigno L
    J Pept Sci; 2009 Mar; 15(3):175-83. PubMed ID: 19035567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.